Cargando…
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions
BACKGROUND: Frailty is common in clinical practice, but trials rarely report on participant frailty. Consequently, clinicians and guideline-developers assume frailty is largely absent from trials and have questioned the relevance of trial findings to frail people. Therefore, we examined frailty in p...
Autores principales: | Hanlon, Peter, Butterly, Elaine, Lewsey, Jim, Siebert, Stefan, Mair, Frances S., McAllister, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579922/ https://www.ncbi.nlm.nih.gov/pubmed/33087107 http://dx.doi.org/10.1186/s12916-020-01752-1 |
Ejemplares similares
-
An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes
por: Hanlon, Peter, et al.
Publicado: (2021) -
Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis
por: Hanlon, Peter, et al.
Publicado: (2020) -
Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol
por: Hanlon, Peter, et al.
Publicado: (2020) -
Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition
por: Wightman, Heather, et al.
Publicado: (2023) -
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
por: Hanlon, Peter, et al.
Publicado: (2023)